327 related articles for article (PubMed ID: 28799673)
21. Growth differentiation factor-15: a p53- and demethylation-upregulating gene represses cell proliferation, invasion, and tumorigenesis in bladder carcinoma cells.
Tsui KH; Hsu SY; Chung LC; Lin YH; Feng TH; Lee TY; Chang PL; Juang HH
Sci Rep; 2015 Aug; 5():12870. PubMed ID: 26249737
[TBL] [Abstract][Full Text] [Related]
22. The TPX2 gene is a promising diagnostic and therapeutic target for cervical cancer.
Chang H; Wang J; Tian Y; Xu J; Gou X; Cheng J
Oncol Rep; 2012 May; 27(5):1353-9. PubMed ID: 22307108
[TBL] [Abstract][Full Text] [Related]
23. Overexpressed targeting protein for Xklp2 (TPX2) serves as a promising prognostic marker and therapeutic target for gastric cancer.
Liang B; Zheng W; Fang L; Wu L; Zhou F; Yin X; Yu X; Zou Z
Cancer Biol Ther; 2016 Aug; 17(8):824-32. PubMed ID: 27314162
[TBL] [Abstract][Full Text] [Related]
24. TPX2 is a novel prognostic marker for the growth and metastasis of colon cancer.
Wei P; Zhang N; Xu Y; Li X; Shi D; Wang Y; Li D; Cai S
J Transl Med; 2013 Dec; 11():313. PubMed ID: 24341487
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of G2 and S phase-expressed-1 contributes to cell proliferation, migration, and invasion via regulating p53/FoxM1/CCNB1 pathway and predicts poor prognosis in bladder cancer.
Liu A; Zeng S; Lu X; Xiong Q; Xue Y; Tong L; Xu W; Sun Y; Zhang Z; Xu C
Int J Biol Macromol; 2019 Feb; 123():322-334. PubMed ID: 30414902
[TBL] [Abstract][Full Text] [Related]
26. GLI pathogenesis-related 1 functions as a tumor-suppressor in lung cancer.
Sheng X; Bowen N; Wang Z
Mol Cancer; 2016 Mar; 15():25. PubMed ID: 26988096
[TBL] [Abstract][Full Text] [Related]
27. Systemic GLIPR1-ΔTM protein as a novel therapeutic approach for prostate cancer.
Karantanos T; Tanimoto R; Edamura K; Hirayama T; Yang G; Golstov AA; Wang J; Kurosaka S; Park S; Thompson TC
Int J Cancer; 2014 Apr; 134(8):2003-13. PubMed ID: 24590455
[TBL] [Abstract][Full Text] [Related]
28. BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cells.
Tsui KH; Chiang KC; Lin YH; Chang KS; Feng TH; Juang HH
Cancer Med; 2018 Jan; 7(1):184-195. PubMed ID: 29239139
[TBL] [Abstract][Full Text] [Related]
29. TPX2 Level Correlates with Hepatocellular Carcinoma Cell Proliferation, Apoptosis, and EMT.
Liang B; Jia C; Huang Y; He H; Li J; Liao H; Liu X; Liu X; Bai X; Yang D
Dig Dis Sci; 2015 Aug; 60(8):2360-72. PubMed ID: 26025609
[TBL] [Abstract][Full Text] [Related]
30. TPX2 in malignantly transformed human bronchial epithelial cells by anti-benzo[a]pyrene-7,8-diol-9,10-epoxide.
Zhang L; Huang H; Deng L; Chu M; Xu L; Fu J; Zhu Y; Zhang X; Liu S; Zhou Z; Wang Y
Toxicology; 2008 Oct; 252(1-3):49-55. PubMed ID: 18723071
[TBL] [Abstract][Full Text] [Related]
31. GLIPR1 inhibits the proliferation and induces the differentiation of cancer-initiating cells by regulating miR-16 in osteosarcoma.
Dong J; Bi B; Zhang L; Gao K
Oncol Rep; 2016 Sep; 36(3):1585-91. PubMed ID: 27460987
[TBL] [Abstract][Full Text] [Related]
32. MiR-491 suppresses migration and invasion via directly targeting TPX2 in breast cancer.
Tan GZ; Li M; Tan X; Shi ML; Mou K
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9996-10004. PubMed ID: 31799669
[TBL] [Abstract][Full Text] [Related]
33. TPX2 is a prognostic marker and contributes to growth and metastasis of human hepatocellular carcinoma.
Huang Y; Guo W; Kan H
Int J Mol Sci; 2014 Oct; 15(10):18148-61. PubMed ID: 25302620
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic potential of targeting protein for Xklp2 silencing for pancreatic cancer.
Miwa T; Kokuryo T; Yokoyama Y; Yamaguchi J; Nagino M
Cancer Med; 2015 Jul; 4(7):1091-100. PubMed ID: 25914189
[TBL] [Abstract][Full Text] [Related]
35. High expression of TMEM40 is associated with the malignant behavior and tumorigenesis in bladder cancer.
Zhang ZF; Zhang HR; Zhang QY; Lai SY; Feng YZ; Zhou Y; Zheng SR; Shi R; Zhou JY
J Transl Med; 2018 Jan; 16(1):9. PubMed ID: 29351801
[TBL] [Abstract][Full Text] [Related]
36. CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration.
Gong Y; Qiu W; Ning X; Yang X; Liu L; Wang Z; Lin J; Li X; Guo Y
Oncotarget; 2015 Sep; 6(28):25856-67. PubMed ID: 26312564
[TBL] [Abstract][Full Text] [Related]
37. GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin.
Gong X; Liu J; Zhang D; Yang D; Min Z; Wen X; Wang G; Li H; Song Y; Bai C; Li J; Zhou J
PLoS One; 2017; 12(8):e0182410. PubMed ID: 28771580
[TBL] [Abstract][Full Text] [Related]
38. Reduced Expression of Metastasis Suppressor-1 (MTSS1) Accelerates Progression of Human Bladder Uroepithelium Cell Carcinoma.
Du P; Wang S; Tang X; An C; Yang Y; Jiang WG
Anticancer Res; 2017 Aug; 37(8):4499-4505. PubMed ID: 28739745
[TBL] [Abstract][Full Text] [Related]
39. The AURKA/TPX2 axis drives colon tumorigenesis cooperatively with MYC.
Takahashi Y; Sheridan P; Niida A; Sawada G; Uchi R; Mizuno H; Kurashige J; Sugimachi K; Sasaki S; Shimada Y; Hase K; Kusunoki M; Kudo S; Watanabe M; Yamada K; Sugihara K; Yamamoto H; Suzuki A; Doki Y; Miyano S; Mori M; Mimori K
Ann Oncol; 2015 May; 26(5):935-942. PubMed ID: 25632068
[TBL] [Abstract][Full Text] [Related]
40. Knockdown of KNTC1 Inhibits the Proliferation, Migration and Tumorigenesis of Human Bladder Cancer Cells and Induces Apoptosis.
Huang H; Fan X; Qiao Y; Yang M; Ji Z
Crit Rev Eukaryot Gene Expr; 2021; 31(1):49-60. PubMed ID: 33639055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
